Literature DB >> 16547467

Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases.

Stephen M Bonsib1.   

Abstract

Although renal sinus vein invasion is the most common site of extrarenal involvement in clear cell renal cell carcinoma (CC), CC also spreads by lymphatics. As cortical lymphatics drain into the sinus, some involved sinus structures may be lymphatics, not veins. This possibility was investigated with podoplanin, a specific lymphatic endothelial marker, in 40 CC with sinus vein invasion. Ten blocks of uninvolved kidney, serving as controls, showed lymphatics within the adventitia of midcortical intralobular arteries. Lymphatics became more numerous and enlarged with progression towards the medulla. No lymphatics were among glomeruli or within the medulla unless associated with inflammation. The largest lymphatics occurred within the sinus, and were also noted within pelvic muscularis, and media of large veins. Intralymphatic tumor was observed and divided into two Groups. Group 1 (four cases) involved lymphatics within the invasive edge of tumors lacking a pseudocapsule. The lymphatics were small (0.045-0.19 mm), irregularly shaped, often incomplete, and contained single cells or small clusters of tumor cells. Group 2 (four cases) involved sinus lymphatics separate from tumor. One case each also involved adventitial lymphatics of an intralobular artery, the muscularis of the renal pelvis, and media of a muscular vein. The intralymphatic tumor in Group 2 often appeared discohesive, not endothelial cell invested, and larger than in Group 1 (0.4-0.5 mm). Conversely, tumor within muscular veins was cohesive, contained a capillary plexis, and was endothelial cell invested. In conclusion, intralymphatic tumor can be demonstrated in CC. Lymphatic involvement is less frequent than venous involvement and involves smaller structures. The potential for lymphatic spread may not be equal among involved lymphatics. Small peritumoral lymphatics may be destined for destruction by tumor growth. However, involved lymphatics within sinus and associated with renal pelvis, are likely sources for lymphatic spread and lymph node metastases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547467     DOI: 10.1038/modpathol.3800589

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.

Authors:  Andrew Feifer; Caroline Savage; Heidi Rayala; William Lowrance; Geoffrey Gotto; Preston Sprenkle; Amit Gupta; Jennifer Taylor; Melanie Bernstein; Adebowale Adeniran; Satish K Tickoo; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung.

Authors:  Francesca Sozio; Antonella Rossi; Elisabetta Weber; David J Abraham; Andrew G Nicholson; Athol U Wells; Elisabetta A Renzoni; Piersante Sestini
Journal:  J Anat       Date:  2012-01-30       Impact factor: 2.610

3.  Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.

Authors:  Liping Shi; Long Xiao; Baoli Heng; Shijie Mo; Weijun Chen; Zexuan Su
Journal:  Int Urol Nephrol       Date:  2017-03-27       Impact factor: 2.370

Review 4.  [Renal cancer biomarkers. What is justified?].

Authors:  H Moch
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 5.  Biomarkers in renal cancer.

Authors:  Holger Moch; John Srigley; Brett Delahunt; Rodolfo Montironi; Lars Egevad; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

6.  Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants.

Authors:  Sharon Phillips; Meghan Kapp; Deborah Crowe; Jorge Garces; Agnes B Fogo; Giovanna A Giannico
Journal:  Hum Pathol       Date:  2016-01-14       Impact factor: 3.466

7.  [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].

Authors:  H Moch
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

8.  Metastatic Clear Cell Renal Cell Carcinoma Presenting with a Gingival Metastasis.

Authors:  Rusha A E Ali; Kamal E H Mohamed
Journal:  Clin Pract       Date:  2016-06-10

9.  Extent of renal vein invasion influences prognosis in patients with renal cell carcinoma.

Authors:  Mark W Ball; Michael A Gorin; Kelly T Harris; Kevin M Curtiss; George J Netto; Christian P Pavlovich; Phillip M Pierorazio; Mohamad E Allaf
Journal:  BJU Int       Date:  2015-11-14       Impact factor: 5.588

10.  Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma.

Authors:  Yu Xia; Li Liu; Ying Xiong; Qi Bai; Jiajun Wang; Wei Xi; Yang Qu; Jiejie Xu; Jianming Guo
Journal:  Cancer Sci       Date:  2016-09-01       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.